The 2011 European Pharma Manufacturing Masters will focus on increasing operational excellence and the restructuring of business units. The event aims to discuss the upcoming expirations of blockbuster drug patents, a dwindling pipeline of blockbuster drugs, increased pressure from generic drugs, energy consumption and uncertainty about the future of healthcare reimbursement in the United States.
Greg Liposky will discuss "2011 Challenges & Success Factors in Start-up and Operation of a New Manufacturing Facility."
MedImmune is a sponsor.
Added by MedImmune on January 13, 2011